COVIDIEN MANUFACTURING GRENOBLE : revenue, balance sheet and financial ratios

COVIDIEN MANUFACTURING GRENOBLE is a French company founded 41 years ago, specialized in the sector Fabrication de matériel médico-chirurgical et dentaire. Based in LE PONT-DE-CLAIX (38800), this company of category ETI shows in 2025 a revenue of 26.9 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - COVIDIEN MANUFACTURING GRENOBLE (SIREN 331407742)
Indicator 2025 2024 2023 2022 2021 2020 2019 2019 2018 2017
Revenue 26 859 447 € 26 530 800 € 21 786 838 € 20 693 298 € 18 628 779 € 19 346 743 € 18 587 401 € 18 587 401 € 19 120 159 € 20 487 503 €
Net income 2 319 472 € 1 191 174 € 1 079 152 € 854 427 € 1 256 784 € 1 197 519 € 1 344 895 € 1 344 895 € 1 627 591 € 1 787 778 €
EBITDA 4 305 378 € 2 438 427 € 2 204 256 € 1 939 761 € 2 953 537 € 2 666 320 € 2 328 002 € 2 328 002 € 2 495 977 € 2 673 947 €
Net margin 8.6% 4.5% 5.0% 4.1% 6.7% 6.2% 7.2% 7.2% 8.5% 8.7%

Revenue and income statement

In 2025, COVIDIEN MANUFACTURING GRENOBLE achieves revenue of 26.9 M€. Revenue is growing positively over 10 years (CAGR: +3.4%). Vs 2024: +1%. After deducting consumption (1.9 M€), gross margin stands at 24.9 M€, i.e. a rate of 93%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 4.3 M€, representing 16.0% of revenue. Positive scissor effect: EBITDA margin improves by +6.8 pts, sign of improved operational efficiency. This high EBITDA margin provides strong self-financing capacity and resilience to uncertainties. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 2.3 M€, i.e. 8.6% of revenue. This profit can be retained or distributed to shareholders.

Revenue (2025) ?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production

26 859 447 €

Gross margin (2025) ?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed

24 926 857 €

EBITDA (2025) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

4 305 378 €

EBIT (2025) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

3 124 159 €

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

2 319 472 €

EBITDA margin (2025) ?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability
5-10% : Average
< 5% : Low

16.0%

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 66%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Cash flow represents 13.1% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

0.0%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

66.096%

Cash flow / Revenue (2025) ?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates

13.11%

Repayment capacity (2025) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

0.0

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

35.9%

Solvency indicators evolution
COVIDIEN MANUFACTURING GRENOBLE

Sector positioning

Debt ratio
0.0 2025
2023
2024
2025
Q1: 5.49
Med: 17.07
Q3: 41.92
Excellent

In 2025, the debt ratio of COVIDIEN MANUFACTURING GR... (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
66.1% 2025
2023
2024
2025
Q1: 36.67%
Med: 56.53%
Q3: 69.09%
Good -6 pts over 3 years

In 2025, the financial autonomy of COVIDIEN MANUFACTURING GR... (66.1%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Repayment capacity
0.0 years 2025
2023
2024
2025
Q1: 0.0 years
Med: 0.66 years
Q3: 1.52 years
Excellent

In 2025, the repayment capacity of COVIDIEN MANUFACTURING GR... (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 247.70. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

247.704

Interest coverage (2025) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

0.0

Liquidity indicators evolution
COVIDIEN MANUFACTURING GRENOBLE

Sector positioning

Liquidity ratio
247.7 2025
2023
2024
2025
Q1: 181.98
Med: 251.18
Q3: 365.98
Average -16 pts over 3 years

In 2025, the liquidity ratio of COVIDIEN MANUFACTURING GR... (247.70) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Interest coverage
0.0x 2025
2023
2024
2025
Q1: 0.0x
Med: 0.83x
Q3: 3.14x
Average -25 pts over 3 years

In 2025, the interest coverage of COVIDIEN MANUFACTURING GR... (0.0x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 72 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 197 days. Excellent situation: suppliers finance 125 days of the operating cycle (retail model). Inventory turnover is 33 days (= Average inventory / Cost of goods x 360). Fast turnover, sign of good inventory management. Overall, WCR represents 63 days of revenue, i.e. 4.7 M€ to permanently finance. Notable WCR improvement over the period (-82%), freeing up cash.

Operating WCR (2025) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

4 682 139 €

Customer credit (2025) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

72 j

Supplier credit (2025) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

197 j

Inventory turnover (2025) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

33 j

WCR in days of revenue (2025) ?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management

63 j

WCR and payment terms evolution
COVIDIEN MANUFACTURING GRENOBLE

Positioning of COVIDIEN MANUFACTURING GRENOBLE in its sector

Comparison with sector Fabrication de matériel médico-chirurgical et dentaire

Valuation estimate

Based on 57 transactions of similar company sales (all years), the value of COVIDIEN MANUFACTURING GRENOBLE is estimated at 8 706 846 € (range 2 252 033€ - 16 719 127€). With an EBITDA of 4 305 378€, the sector multiple of 2.5x is applied. The price/revenue ratio is 0.23x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.

Estimated enterprise value 2025
57 tx
2252k€ 8706k€ 16719k€
8 706 846 € Range: 2 252 033€ - 16 719 127€
NAF 5 all-time

Valuation detail by method

Ajustez les pondérations selon votre analyse

EBITDA Multiple 50%
4 305 378 € × 2.5x
Estimation 10 932 905 €
2 148 716€ - 20 218 455€
Revenue Multiple 30%
26 859 447 € × 0.23x
Estimation 6 091 733 €
2 831 137€ - 12 745 918€
Net Income Multiple 20%
2 319 472 € × 3.0x
Estimation 7 064 370 €
1 641 670€ - 13 930 622€
How is this estimate calculated?

This estimate is based on the analysis of 57 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Fabrication de matériel médico-chirurgical et dentaire)

Compare COVIDIEN MANUFACTURING GRENOBLE with other companies in the same sector:

Voir toutes les statistiques du secteur Fabrication de matériel médico-chirurgical et dentaire

Frequently asked questions about COVIDIEN MANUFACTURING GRENOBLE

What is the revenue of COVIDIEN MANUFACTURING GRENOBLE ?

The revenue of COVIDIEN MANUFACTURING GRENOBLE in 2025 is 26.9 M€.

Is COVIDIEN MANUFACTURING GRENOBLE profitable?

Yes, COVIDIEN MANUFACTURING GRENOBLE generated a net profit of 2.3 M€ in 2025.

Where is the headquarters of COVIDIEN MANUFACTURING GRENOBLE ?

The headquarters of COVIDIEN MANUFACTURING GRENOBLE is located in LE PONT-DE-CLAIX (38800), in the department Isere.

Where to find the tax return of COVIDIEN MANUFACTURING GRENOBLE ?

The tax return of COVIDIEN MANUFACTURING GRENOBLE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does COVIDIEN MANUFACTURING GRENOBLE operate?

COVIDIEN MANUFACTURING GRENOBLE operates in the sector Fabrication de matériel médico-chirurgical et dentaire (NAF code 32.50A). See the 'Sector positioning' section above to compare the company with its competitors.